Medpace Holdings, Inc. (MEDP) NASDAQ

445.59

-5.88(-1.30%)

Updated at June 02 04:00PM

Currency In USD

Medpace Holdings, Inc.

Address

5375 Medpace Way

Cincinnati, OH 45227

United States of America (the)

Phone

513 579 9911

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

5900

First IPO Date

August 11, 2016

Key Executives

NameTitlePayYear Born
August James TroendleChairman & Chief Executive Officer1.44M1956
Kevin BradyChief Financial Officer & Treasurer646,1451975
Jesse J. GeigerPresident896,3671974
Stephen EwaldChief Compliance Officer, General Counsel & Corporate Secretary1.02M1969
Susan E. BurwigExecutive Vice President of Operations1.22M1963
John T. WynneSenior Vice President of Commercial Operations & Clinical Pharmacology Unit0N/A
Todd MeyersVice President of Business Development & Marketing0N/A
Weimin GaiSenior Vice President of Biometrics0N/A
Gina LeisringSenior Vice President of Clinical Monitoring0N/A
Lauren MorrisAssociate Director of Investors Relations0N/A
Reinilde HeyrmanChief Medical Officer of Medical Department01961
Brandon EbkenChief Information Officer0N/A

Description

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.